Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE)

Diabetologia

Volumn 53, Issue 12, 2010, Pages 2656-2666

  Zong, H ^a   Ward, M ^a   Madden, A ^a   Yong, P H ^a   Limb, G A ^b   Curtis, T M ^a   Stitt, A W ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cytokine; Diabetic retinopathy; Inflammation; MAPK; M ller glia; RAGE; S100B

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN S100B; SMALL INTERFERING RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC RETINOPATHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MUELLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

ANIMALS; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; GLUCOSE; HUMANS; HYPERGLYCEMIA; INFLAMMATION MEDIATORS; MALE; NEUROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; RETINA; RETINITIS; STREPTOZOCIN;

EID: 78649333713     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1900-z     Document Type: Article

References (46)

1. TM Curtis TA Gardiner AW Stitt 2009 Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond) 23 1496 1508 1:STN:280:DC%2BD1MvovVygsg%3D%3D
2. A Bringmann T Pannicke J Grosche, et al. 2006 Muller cells in the healthy and diseased retina Prog Retin Eye Res 25 397 424 1:CAS:528: DC%2BD28XntVWgs7g%3D 10.1016/j.preteyeres.2006.05.003 16839797 (Pubitemid 44038611)
3. C Gerhardinger LF Brown S Roy M Mizutani CL Zucker M Lorenzi 1998 Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy Am J Pathol 152 1453 1462 1:CAS:528:DyaK1cXktVSkurc%3D 9626050
4. E Lieth AJ Barber B Xu, et al. 1998 Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group Diabetes 47 815 820 1:CAS:528:DyaK1cXjs1Sgsbg%3D 10.2337/diabetes.47.5.815 9588455 (Pubitemid 28201813)
5. Y Bai JX Ma J Guo, et al. 2009 Muller cell-derived VEGF is a significant contributor to retinal neovascularization J Pathol 219 446 454 1:CAS:528:DC%2BC3cXjsVKrtw%3D%3D 10.1002/path.2611 19768732
6. T Pannicke I Iandiev A Wurm, et al. 2006 Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina Diabetes 55 633 639 1:CAS:528:DC%2BD28XisVWisrY%3D 10.2337/diabetes.55.03.06.db05-1349 16505225
7. AM Joussen V Poulaki ML Le, et al. 2004 A central role for inflammation in the pathogenesis of diabetic retinopathy FASEB J 18 1450 1452 1:CAS:528:DC%2BD2cXntlKktLs%3D 15231732 (Pubitemid 39561611)
8. C Gerhardinger Z Dagher P Sebastiani YS Park M Lorenzi 2009 The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy Diabetes 58 1659 1667 1:CAS:528: DC%2BD1MXos1Cqu7g%3D 10.2337/db08-1008 19401417
9. RM Brucklacher KM Patel HD Van Guilder, et al. 2008 Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response BMC Med Genomics 1 26 10.1186/1755-8794-1-26
10. AM Vincent L Perrone KA Sullivan, et al. 2007 Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress Endocrinology 148 548 558 1:CAS:528:DC%2BD2sXhtlOjtrs%3D 10.1210/en.2006-0073 17095586 (Pubitemid 46143159)
11. E Rungger-Brandle AA Dosso PM Leuenberger 2000 Glial reactivity, an early feature of diabetic retinopathy Invest Ophthalmol Vis Sci 41 1971 1980 1:STN:280:DC%2BD3czgt1antQ%3D%3D 10845624
12. C Gerhardinger MB Costa MC Coulombe I Toth T Hoehn P Grosu 2005 Expression of acute-phase response proteins in retinal Muller cells in diabetes Invest Ophthalmol Vis Sci 46 349 357 10.1167/iovs.04-0860 15623795 (Pubitemid 40041218)
13. AM Schmidt M Hofmann A Taguchi SD Yan DM Stern 2000 RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation Semin Thromb Hemost 26 485 493 1:CAS:528:DC%2BD3cXptVamsr8%3D 10.1055/s-2000-13204 11129404
14. SF Yan R Ramasamy AM Schmidt 2010 The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature Circ Res 106 842 853 1:CAS:528:DC%2BC3cXjs1aku7w%3D 10.1161/CIRCRESAHA.109.212217 20299674
15. M Neeper AM Schmidt J Brett, et al. 1992 Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins J Biol Chem 267 14998 15004 1:CAS:528:DyaK3sXktVGnt7w%3D 1378843
16. CH Yeh L Sturgis J Haidacher, et al. 2001 Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion Diabetes 50 1495 1504 1:CAS:528:DC%2BD3MXkvFSgt78%3D 10.2337/diabetes.50.6.1495 11375353
17. HJ Huttunen C Fages H Rauvala 1999 Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways J Biol Chem 274 19919 19924 1:CAS:528:DyaK1MXksFKmu74%3D 10.1074/jbc.274.28.19919 10391939 (Pubitemid 29327777)
18. A Hirose T Tanikawa H Mori Y Okada Y Tanaka 2010 Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway FEBS Lett 584 61 66 1:CAS:528:DC%2BD1MXhsFGgur7I 10.1016/j.febslet.2009. 11.082 19944695
19. JS Huang JY Guh HC Chen WC Hung YH Lai LY Chuang 2001 Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells J Cell Biochem 81 102 113 1:CAS:528:DC%2BD3MXhs12gtLY%3D 10.1002/1097-4644(20010401)81:1<102::AID- JCB1027>3.0.CO;2-Y 11180401 (Pubitemid 32202743)
20. R Ramasamy SF Yan AM Schmidt 2005 The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond Trends Cardiovasc Med 15 237 243 1:CAS:528:DC%2BD2MXhtFWhtL7K 10.1016/j.tcm.2005.08.003 16226677 (Pubitemid 41437905)
21. GR Barile SI Pachydaki SR Tari, et al. 2005 The RAGE axis in early diabetic retinopathy Invest Ophthalmol Vis Sci 46 2916 2924 10.1167/iovs.04-1409 16043866 (Pubitemid 43086714)
22. T Soulis V Thallas S Youssef, et al. 1997 Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury Diabetologia 40 619 628 1:CAS:528:DyaK2sXkt1yqurY%3D 10.1007/s001250050725 9222639 (Pubitemid 27288105)
23. HP Hammes H Hoerauf A Alt, et al. 1999 N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration Invest Ophthalmol Vis Sci 40 1855 1859 1:STN:280:DyaK1MzitVagsA%3D%3D 10393061
24. A Stitt TA Gardiner NL Alderson, et al. 2002 The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes Diabetes 51 2826 2832 1:CAS:528:DC%2BD38Xmsleru7o%3D 10.2337/diabetes.51.9.2826 12196477
25. SI Pachydaki SR Tari SE Lee, et al. 2006 Upregulation of RAGE and its ligands in proliferative retinal disease Exp Eye Res 82 807 815 1:CAS:528:DC%2BD28XhtFejsrw%3D 10.1016/j.exer.2005.09.022 16364297 (Pubitemid 43170881)
26. D Yao M Brownlee 2010 Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands Diabetes 59 249 255 1:CAS:528:DC%2BC3cXmtVKmtA%3D%3D 10.2337/db09-0801 19833897
27. GA Limb TE Salt PM Munro SE Moss PT Khaw 2002 In vitro characterization of a spontaneously immortalized human Muller cell line (MIO-M1) Invest Ophthalmol Vis Sci 43 864 869 11867609
28. F Brozzi C Arcuri I Giambanco R Donato 2009 S100B protein regulates astrocyte shape and migration via interaction with Src kinase: implications for astrocyte development, activation, and tumor growth J Biol Chem 284 8797 8811 1:CAS:528:DC%2BD1MXjsVSitLc%3D 10.1074/jbc.M805897200 19147496
29. KA Howes Y Liu JL Dunaief, et al. 2004 Receptor for advanced glycation end products and age-related macular degeneration Invest Ophthalmol Vis Sci 45 3713 3720 10.1167/iovs.04-0404 15452081 (Pubitemid 39298589)
30. JV Busik S Mohr MB Grant 2008 Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators Diabetes 57 1952 1965 1:CAS:528:DC%2BD1cXosVKltrk%3D 10.2337/db07-1520 18420487
31. LG Bucciarelli T Wendt W Qu, et al. 2002 RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice Circulation 106 2827 2835 1:CAS:528:DC%2BD38XoslSnsLs%3D 10.1161/01.CIR.0000039325.03698.36 12451010 (Pubitemid 35396983)
32. SF Yan R Ramasamy AM Schmidt 2008 Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications Nat Clin Pract Endocrinol Metab 4 285 293 1:CAS:528: DC%2BD1cXkvFWmt7o%3D 10.1038/ncpendmet0786 18332897 (Pubitemid 351571138)
33. PJ Thornalley 2007 Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE)-an introduction Mol Nutr Food Res 51 1107 1110 1:CAS:528:DC%2BD2sXhtFOnu73I 10.1002/mnfr.200700017 17854008 (Pubitemid 47522803)
34. R Ramasamy SF Yan AM Schmidt 2007 Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts Mol Nutr Food Res 51 1111 1115 1:CAS:528:DC%2BD2sXhtFOnu73J 10.1002/mnfr.200700008 17854009 (Pubitemid 47522804)
35. Y Izumi CO Kirby AM Benz JW Olney CF Zorumski 1999 Muller cell swelling, glutamate uptake, and excitotoxic neurodegeneration in the isolated rat retina Glia 25 379 389 1:STN:280:DyaK1M7ltFekug%3D%3D 10.1002/(SICI)1098-1136(19990215) 25:4<379::AID-GLIA7>3.0.CO;2-7 10028920 (Pubitemid 29083837)
36. R Donato 2001 S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles Int J Biochem Cell Biol 33 637 668 1:CAS:528:DC%2BD3MXktVKltro%3D 10.1016/S1357- 2725(01)00046-2 11390274 (Pubitemid 32520962)
37. R Donato G Sorci F Riuzzi, et al. 2009 S100B's double life: intracellular regulator and extracellular signal Biochim Biophys Acta 1793 1008 1022 1:CAS:528:DC%2BD1MXntVGrsbs%3D 10.1016/j.bbamcr.2008.11.009 19110011
38. MG Rambotti I Giambanco A Spreca R Donato 1999 S100B and S100A1 proteins in bovine retina: their calcium-dependent stimulation of a membrane-bound guanylate cyclase activity as investigated by ultracytochemistry Neuroscience 92 1089 1101 1:CAS:528:DyaK1MXktlCrtrY%3D 10.1016/S0306-4522(99)00074-3 10426548 (Pubitemid 29287553)
39. P Nardin F Tramontina MC Leite, et al. 2007 S100B content and secretion decrease in astrocytes cultured in high-glucose medium Neurochem Int 50 774 782 1:CAS:528:DC%2BD2sXjsVGjtrk%3D 10.1016/j.neuint.2007.01.013 17350141 (Pubitemid 46452846)
40. G Baydas VS Nedzvetskii M Tuzcu A Yasar SV Kirichenko 2003 Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E Eur J Pharmacol 462 67 71 1:CAS:528: DC%2BD3sXht1Klu7w%3D 10.1016/S0014-2999(03)01294-9 12591097 (Pubitemid 36183736)
41. H Zong A Madden M Ward MH Mooney CT Elliott AW Stitt 2010 Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction J Biol Chem 285 23137 23146 1:CAS:528:DC%2BC3cXovFelsrw%3D 10.1074/jbc.M110.133827 20504772
42. MD Shelton TS Kern JJ Mieyal 2007 Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Muller cells: model of diabetic retinopathy J Biol Chem 282 12467 12474 1:CAS:528:DC%2BD2sXksVSjtbk%3D 10.1074/jbc.M610863200 17324929 (Pubitemid 47100623)
43. HY Zeng WR Green MO Tso 2008 Microglial activation in human diabetic retinopathy Arch Ophthalmol 126 227 232 10.1001/archophthalmol.2007.65 18268214 (Pubitemid 351240852)
44. L Perrone TS Devi K Hosoya T Terasaki LP Singh 2009 Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions J Cell Physiol 221 262 272 1:CAS:528:DC%2BD1MXptlOntL0%3D 10.1002/jcp.21852 19562690
45. TN Crawford DV Alfaro 3rd JB Kerrison EP Jablon 2009 Diabetic retinopathy and angiogenesis Curr Diabetes Rev 5 8 13 1:CAS:528:DC%2BC3cXislyit7s%3D 10.2174/157339909787314149 19199892
46. T Nakazawa T Hisatomi C Nakazawa, et al. 2007 Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis Proc Natl Acad Sci USA 104 2425 2430 1:CAS:528:DC%2BD2sXisVShtrc%3D 10.1073/pnas. 0608167104 17284607 (Pubitemid 46391413)